Bay Street News, November, 2018

Clinical data from the first cohort of Phase I study for the treatment of incomplete hematopoietic recovery following hematopoietic cell […]

WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the […]

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) — Kyber Data Science, LLC, a wholly-owned subsidiary of Cowen Inc. (NASDAQ:COWN) (“Cowen” […]

MagneGas Recognized for Innovation at Maritime2020 Asia Summit TAMPA, Fla., Nov. 28, 2018 (GLOBE NEWSWIRE) — MagneGas Applied Technology Solutions, […]

Research partner City of Hope to present initial safety and efficacy Phase 1 data in relapsed or refractory acute myeloid […]

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Jay McDermott […]

GREENSBORO, N.C., Nov. 28, 2018 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect […]

OMAHA, Neb., Nov. 28, 2018 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced that it has completed the previously […]

OTTAWA, Nov. 28, 2018 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY) reports that its health services team has further […]

VANCOUVER, B.C. and SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug […]